logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Norwegian Radium Hospital

+4722934000
Source: Site record.
https://www.oslo-universitetssykehus.no/steder/radiumhospitalet

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Norwegian Radium Hospital (Radiumhospitalet), located at Ullernchausseen 70, 0379 Oslo, Norway, is Scandinavia's largest specialized cancer centre and a core component of Oslo University Hospital. Founded in 1932, it operates as an internationally accredited Comprehensive Cancer Centre seamlessly integrating clinical care, advanced research, and clinical trials on a sprawling 105,000-square-meter campus.

Business Status

Source: Google. OPEN

Business Category

Source: Google. University hospital

Business Subcategory

Source: Google. University hospital
Source: Google. Hospital
Source: Trial-derived.
28Total Trials
Source: Trial-derived.
7Recruiting Trials
Source: Trial-derived.
11Active Trials
Source: Trial-derived.
13Completed Trials
Source: Trial-derived.
42Unique Conditions
Source: Trial-derived.
35Unique Sponsors

Conditions

Source: Trial-derived. Ovarian Cancer (3)Source: Trial-derived. Colo-rectal Cancer (2)Source: Trial-derived. Melanoma (2)Source: Trial-derived. Peritoneal Carcinomatosis (2)Source: Trial-derived. Prostate Cancer (2)Source: Trial-derived. Advanced Gastrointestinal Stromal Tumor (1)Source: Trial-derived. Advanced Malignancies (1)Source: Trial-derived. Advanced/Metastatic Melanoma (1)

Sponsors

Source: Trial-derived. Oslo University Hospital (8)Source: Trial-derived. Merck Sharp & Dohme LLC (3)Source: Trial-derived. Hoffmann-La Roche (2)Source: Trial-derived. Oncoinvent Solutions AS (2)Source: Trial-derived. Seagen, a wholly owned subsidiary of Pfizer (2)Source: Trial-derived. Ariad Pharmaceuticals (1)Source: Trial-derived. Arog Pharmaceuticals, Inc. (1)Source: Trial-derived. Australasian Gastro-Intestinal Trials Group (1)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. MRI

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Specimen packaging and shipment

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. RAS mutation testing
Source: AI-inferred. Tumour BRAF V600 mutation testing